Back to results
US 2024/0200152 A1Published application
Primer set, reagent composition and method for the detection of methicillin-resistant staphylococcus aureus (mrsa)
OwnerMiron TOKARSKI, Malgorzata MALODOBRA-MAZURinventors
Life of this patent
Estimating the term…
Abstract
The invention relates to a set of primers, a composition of reagents and a method for detecting methicillin-resistant Staphylococcus aureus (MRSA) bacteria.
Claims20
A set of primers for amplifying the nucleotide sequence of the methicillin-resistant Staphylococcus aureus (MRSA) mecA gene, characterized in that it comprises a set of internal primers with the following nucleotide sequences a) and b), as well as a set of external primers comprising the following nucleotide sequences c) and d):
- a) 5′ GAAGGTGTGCTTACAAGTGCTAATA 3′ (SEQ ID NO:
- 3) or a sequence at least 90% identical to SEQ ID NO:
- 3, linked from the 3′ end, preferably by a TTTT bridge, to the sequence 5′ CAACATGAAAAATGATTATGGCTC 3′ (SEQ ID NO:
- 4) or a sequence at least 90% identical to SEQ ID NO:
- 4;
- b) 5′ TGACGTCTATCCATTTATGTATGGC 3′ (SEQ ID NO:
- 5) or a sequence at least 90% identical to SEQ ID NO:
- 5, linked from the 3′ end, preferably by a TTTT bridge, to the sequence 5′ AGGTTCTTTTTTTATCTTCGGTTA 3′ (SEQ ID NO:
- 6) or a sequence at least 90% identical to SEQ ID NO:
- 6;
- c) 5′ TGATGCTAAAGTTCAAAAGAGT 3′ (SEQ ID NO:
- 1) or a sequence at least 90% identical to SEQ ID NO:
- 1, and
- d) 5′ GTAATCTGGAACTTGTTGAGC 3′ nucleic sequence (SEQ ID NO:
- 2) or a sequence at least 90% identical to SEQ ID NO:
- 2.
13 more elements
Dependencies are inferred from the claim text.